Drugs / Tissue Repair Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00755911 | Jun 2008 → Dec 2011 | periodontal disorder | University of Michigan | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01065337 Comparator | Aug 2005 → Feb 2009 | — | Ruhr University of Bochum | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tissue Repair Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00755911 ↗ |
| Known as | TRC | “These cells (TRC) will help form bone.” NCT00755911 ↗ |
| Modality | Cell therapy | “Tissue repair cells (TRCs) isolated from bone marrow represent a mixed stem and progenitor population enriched in CD90- and CD14-positive cells.” PMID 22776413 ↗ 2013 |
| Route | Other | “10ml of TRC will be absorbed onto gelfoam carrier and placed in extraction socket.” NCT00755911 ↗ |